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Abstract
Background: Needlestick accidents while handling of infectious material in research laboratories can lead to life-
threatening infections in laboratory personnel. In laboratories working with the lymphocytic choriomeningitis virus
(LCMV), the virus can be transmitted to humans through needlestick injury and lead to serious acute illness up to
meningitis.
Case presentation: We report of a case of LCMV meningitis in a laboratory worker who sustained a penetrating
needlestick injury with a LCMV-contaminated hollow needle whilst disposing of a used syringe into the sharps
waste bin. Four days after needlestick injury the laboratory worker developed a systemic disease: 11 days after
exposure, she was diagnosed with meningitis with clinical signs and symptoms of meningismus, photophobia,
nausea and vomiting, requiring hospitalisation. The PCR was positive for LCMV from the blood sample. 18 days after
exposure, seroconversion confirmed the diagnosis of LCMV-induced meningitis with an increase in specific LCMV-
IgM antibodies to 1:10′240 (day 42: 1:20′480). Ten weeks after exposure, a follow-up titre for IgM returned negative,
whereas IgG titre increased to 1:20′480.
Conclusions: This is the first case report of a PCR-documented LCMV meningitis, coupled with seroconversion,
following needlestick injury. It highlights the importance of infection prevention practices that comprise particularly
well established safety precaution protocols in research laboratories handling this pathogenic virus, because
exposure to even a small amount of LCMV can lead to a severe, life-threatening infection.
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Background
LCMV infection is usually asymptomatic or mild and
self-limiting, but rarely can manifest itself as severe
disease such as meningitis and encephalitis [1]. In
organ transplant recipients and immunocompromised
patients such an infection can be life-threatening [2,
3]. Congenital infections can result in life-long mental
retardation and vision deficits [4]. House mice (Mus
musculus) are the common host of LCMV, a member
of the family of Arenaviridae. Modes of transmission
to humans are bites of infected mice, inhalation of
aerosolized droplets of contaminated body fluids or
inoculation of contaminated materials into broken
skin, the eyes or the mouth [5].
We report of well-documented LCMV-meningitis of
a laboratory worker after needlestick injury confirmed
by serological tests and direct detection of viral RNA
in blood by PCR. A previous case report of
lab-acquired LCMV infection was based on indirect
evidence by serological tests, not direct detection of
viral RNA by PCR [6]. There is no evidence-based
standard drug available for post-exposure prophylaxis:
Therefore, prevention of stab wounds with contami-
nated sharp objects, bite of infected mice and inhal-
ation of contagious droplets, is indispensable to
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protect laboratory worker from occupational severe
infection, leading even to epidemics [7].
This highlights the importance of infect prevention
strategies that comprise particularly well established
safety precaution protocols in research laboratories
handling this pathogenic virus, because exposure to
LCMV can lead to a life-threatening infection.
Case presentation
In May 2017, a young scientist accidently sustained a
penetrating needlestick injury to the left index finger
from a LCMV-contaminated needle, whilst disposing
of a used syringe in a correct manner into the in-
accurate overfilled sharps waste bin. The needle stuck
on a syringe that was used to infect mice with
Lymphocytic choriomeningitis virus (LCMV) variant
clone-13. For its distinct use, the syringe was filled
up with 200 μL fluid solution containing a
LCMV-concentration of 9.15 × 106 Plaque-forming
units (PFU)/ml and was littered after its use, presum-
ably completely emptied. The estimated inoculated
volume was approximately 1 μL (corresponding to
9.15 × 103 PFU). Following strictly the laboratory
safety protocol, first aid measures were taken
immediately after the injury by washing and disinfect-
ing the wound. A check-up at the university emer-
gency room (ER) the same day, with clinical
examination and blood tests remained unremarkable.
As there is no known well-established medicamentous
post-exposure prophylaxis, the patient was discharged
and was advised to return to the ER if any signs of
illness occur.
Four days after needlestick injury, she developed sys-
temic illness, comprising acute severe lower back pain
and fatigue (Fig. 1).
Seven days after exposure, her clinical situation
deteriorated by developing flu-like illness with cough,
pharyngitis, neck pain, fever up to 38.3 °C, chills and
pain in the limbs. She presented to the ER where
physical examination revealed no signs of meningitis
or focal neurological deficits. Blood tests showed
acute leukopenia (2.1 × 109/l) and lymphopenia
(0.57 × 109/l) (Additional file 1: Figure S1), but
C-reactive protein and liver function tests were within
the normal range (data not shown). She was
discharged with symptomatic, pain-relieving therapy.
Nine days after needlestick injury, symptoms of sys-
temic illness, especially headaches and back pain,
Fig. 1 Clinical presentation, symptoms and serological tests over the course of time since the day of needlestick injury (Day 0). On day nine:
detection of LCMV-RNA in the blood plasma by PCR. CNS-symptoms include meningismus, photophobia, nausea and vomiting. (ER:
emergency room)
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relapsed and worsened over time. She was admitted to
the hospital where supportive care measures - rehydra-
tion and intensified pain relief - were established. Cere-
brospinal fluid (CSF) showed cell count in the normal
range as well as protein, glucose and lactate level. Sero-
logical tests were reactive for tick-borne-encephalitis
(IgG and IgM positive) consistent with her known posi-
tive vaccine status. A multiplex polymerase chain reac-
tion (PCR) performed in the CSF, including six bacterial
species, seven viruses and one yeast, remained negative.
MRI of the lumbar spine and the brain showed no evi-
dence for abscess or meningeal enhancement. Thrombo-
cytes dropped from 156 × 109/l to 92 × 109/l and
lymphocytes from 0.57 × 109/l to 0.36 × 109/l, consistent
with onset of acute viral infection (Additional file 1: Fig-
ure S1).
11 days after exposure, she was diagnosed with
meningitis, with clinical signs and symptoms of
meningismus, photophobia, nausea and vomiting, sug-
gesting acute LCMV-meningitis.
Blood plasma samples that were drawn nine days after
injury were simultaneously sent to the Laboratory of
Virology at the University Hospital of Geneva and to the
Bernhard Nocht Institute for Tropical Medicine in Ham-
burg for LCMV-PCR. The Geneva laboratory performed
an LCMV-specific real-time reverse transcriptase
(RT)-PCR assay [8] and reported a positive PCR signal
for LCMV from the blood sample. Although CT-Value
was high, indicating a low viral load (CT Mean 40.868),
the signal was clearly positive. The other reference la-
boratory in Hamburg obtained a negative result using a
conventional RT-PCR assay [9]. LCMV-PCR performed
in two urine samples (day 14 and 15 after exposure) and
in the CSF (day nine after exposure) remained negative,
reported by the Geneva laboratory. Serological testing
was performed in Hamburg by immunofluorescence as-
says using LCMV-infected cells as antigen. At day of the
needlestick injury and ten days after exposure, the
patient was tested negative for LCMV-specific IgM as
well as IgG (Fig. 1).
12 days after exposure the patient improved, and la-
boratory findings returned to normal ranges.
18 days after exposure, seroconversion with an in-
crease in specific LCMV-IgM antibodies to 1:10′240
(day 42: 1:20′480; negative reference < 1:20) was con-
firmed (s. Figure 1). Already to that point of time, an in-
crease in specific LCMV-IgG-antibodies to 1:640 could
be noted (day 42: 1:640; negative reference < 1:20) (s.
Figure 1). Ten weeks after exposure, a follow-up titre for
IgM returned negative, whereas IgG titre increased up
to 1:20′480 (s. Figure 1). Diagnosis of acute LCMV men-
ingitis after needlestick injury was based on epidemio-
logical links and exposure, clinical signs and symptoms,
seroconversion in plasma and detection of virus RNA in
blood plasma by PCR. A diagnostic work-up at the clinic
of neurology did not find any evidence for an alternative
diagnosis.
Discussion and conclusion
House mice are the common host of LCMV, a member
of the family of Arenaviridae. Modes of transmission to
humans are bites of infected rodents, inhalation of
aerosolized droplets of contaminated body fluids or in-
oculation of contaminated materials into broken skin,
the eyes or the mouth [5]. LCMV infection is usually
asymptomatic or mild and self-limiting, but rarely can
manifest itself as meningitis and encephalitis [1]. In
organ transplant recipients and immunocompromised
patients, such infections can be life-threatening [2, 3].
Congenital infections can result in life-long mental re-
tardation and vision deficits [4]. The incubation period
usually is eight to 13 days followed typically by a
biphasic febrile illness [10]. The initial phase begins with
fever, malaise, muscle aches, headache and nausea and is
lasting for about one week [10]. After a few days of
recovery signs of meningoencephalitis occur [10]. Our
patient developed this typical biphasic illness, though it
already occurred four days after exposure. The cause of
the shorter incubation period is most likely the high in-
oculum with which the patient has become infected and
the mode of transmission via direct inoculation in the
skin.
It is of note that even in patients presenting with signs
and symptoms of meningitis, CSF cell count still can be
in the normal range as well as protein, glucose and lac-
tate level.
We assume that the conventional RT-PCR that was
used in Hamburg might be less sensitive than the
LCMV-specific real-time RT-PCR performed in Geneva
leading to the differing results. In vitro, detection limit
of RT-PCR is 20 PFU/mL, whereas RNA-detection of
real-time RT-PCR can succeed with viral amounts of
≤10 PFU/mL [8, 9]. PCR-signal obtained with real-time
RT-PCR was weak but clearly positive (CT Mean
40.868), indicating a very low viral load.
This is the first published case report of well-docu-
mented LCMV-meningitis after needlestick injury con-
firmed by serological tests and direct detection of viral
RNA in blood by PCR. A previous case report of iatro-
genic LCMV infection was based on indirect evidence
by serological tests, not direct virus detection by PCR,
although the inoculum was presumably significantly
higher than in our case [6]. There is no evidence-based
standard drug available for post-exposure prophylaxis.
The role of ribavirin in LCMV infection remains unclear.
In mice, an effectiveness of ribavirin has been demon-
strated, but this effect remains unclear in humans [2].
Prevention of stab wounds with contaminated sharp
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objects, bite of infected mice and inhalation of conta-
gious droplets, is crucial to protect laboratory worker
from iatrogenic infection, leading even to epidemics [7].
LCMV-outbreaks in healthcare workers [11] and labora-
tory personnel [12, 13] are well described. The source of
illness for these outbreaks are rodents that have been in-
fected with LCMV for research purposes. LCMV then
was transmitted to humans either via direct intimate
contact with LCMV-infected rodents [12, 13] or by in-
direct contact via aerosol exposure demonstrating the
risk for transmission [11, 13]. Therefore, laboratory
personnel must be instructed of the possible transmis-
sion routes and clinical presentation of LCMV with re-
petitive instructions on safe handling of LCMV. When
working with LCMV, high quality gloves, goggles and
protective gowns must be worn, as well as appropriate
ventilation systems should be in place where animals are
handled. Surfaces should be routinely disinfected using a
certified compound active against LCMV. In addition, a
standard operating procedure should be available for the
management of unintentional exposure to the virus.
Pregnant women and immunosuppressed persons must
be taught that exposure to even a small amount of this
pathogenic virus can lead to a severe, life-threatening
infection.
In conclusion, this well-documented case of
LCMV-meningitis after needlestick injury highlights the
importance of infection prevention practices in research
laboratories and the need of safe handling of this virus,
whose pathogenicity often is underestimated.
Additional file
Additional file 1: Figure S1: Thrombocytes, neutrophils and
lymphocytes over the course of time after day of needlestick injury. (TIF
27480 kb)
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